1. Home
  2. NTZ vs ADVM Comparison

NTZ vs ADVM Comparison

Compare NTZ & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTZ
  • ADVM
  • Stock Information
  • Founded
  • NTZ 1959
  • ADVM 2006
  • Country
  • NTZ Italy
  • ADVM United States
  • Employees
  • NTZ N/A
  • ADVM N/A
  • Industry
  • NTZ Home Furnishings
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NTZ Consumer Discretionary
  • ADVM Health Care
  • Exchange
  • NTZ Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • NTZ 41.6M
  • ADVM 47.4M
  • IPO Year
  • NTZ 1993
  • ADVM 2014
  • Fundamental
  • Price
  • NTZ $2.67
  • ADVM $2.63
  • Analyst Decision
  • NTZ
  • ADVM Strong Buy
  • Analyst Count
  • NTZ 0
  • ADVM 5
  • Target Price
  • NTZ N/A
  • ADVM $23.80
  • AVG Volume (30 Days)
  • NTZ 3.3K
  • ADVM 304.6K
  • Earning Date
  • NTZ 07-02-2025
  • ADVM 08-11-2025
  • Dividend Yield
  • NTZ N/A
  • ADVM N/A
  • EPS Growth
  • NTZ N/A
  • ADVM N/A
  • EPS
  • NTZ N/A
  • ADVM N/A
  • Revenue
  • NTZ $337,653,480.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • NTZ N/A
  • ADVM N/A
  • Revenue Next Year
  • NTZ N/A
  • ADVM $18.82
  • P/E Ratio
  • NTZ N/A
  • ADVM N/A
  • Revenue Growth
  • NTZ N/A
  • ADVM N/A
  • 52 Week Low
  • NTZ $2.15
  • ADVM $1.78
  • 52 Week High
  • NTZ $6.27
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • NTZ 28.57
  • ADVM 54.24
  • Support Level
  • NTZ $3.25
  • ADVM $2.50
  • Resistance Level
  • NTZ $3.25
  • ADVM $2.75
  • Average True Range (ATR)
  • NTZ 0.13
  • ADVM 0.21
  • MACD
  • NTZ -0.07
  • ADVM 0.05
  • Stochastic Oscillator
  • NTZ 31.90
  • ADVM 76.47

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: